Columbus, OH (PRWEB) February 04, 2014
Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, announces they have launched a new Facebook page to provide the public with the most up-to-date information regarding the ongoing litigation of Risperdal gynecomastia claims. The new Risperdal Side-Effects Facebook page will operate as an adjunct to Wright & Schulte’s main website, and serve as another avenue for clients, potential clients and others who may have questions about the ongoing litigation of product liability lawsuits involving Risperdal. In addition to accessing important information regarding the latest developments in the Risperdal litigation, visitors to the page will be able to link to Wright & Schulte’s website, share their own experiences with the antipsychotic drug, and interact with the Firm’s Risperdal lawyers. Visitors are invited to “Like” the Risperdal lawsuit page to help spread the word about this important legal issue.
Risperdal is an atypical antipsychotic drug used to treat a number of psychiatric disorders, including bipolar disorder and schizophrenia. Court documents indicate that more than 200 Risperdal lawsuits have been filed against Johnson & Johnson in Philadelphia’s Court of Common Pleas in Pennsylvania, all of which allege use of the medication caused patients to suffer serious side effect, including gynecomastia (male breast growth). Bloomberg News reported in October 2012 that Johnson & Johnson reached undisclosed settlements in five Risperdal gynecomastia claims filed in the Pennsylvania litigation just before the cases went to trial. However, dozens of such claims remain unresolved. (In Re: Risperdal Litigation, Case ID. 100300296)
[Bloomberg.com/news/2012-10-04/johnson-johnson-agrees-to-settle-five-rispersal-suits.html, Bloomberg News, October 10, 2012]
According to court documents, some plaintiffs in Risperdal lawsuits that involve gynecomastia allegations claim they were forced to undergo liposuction or mastectomies to remove excess breast tissue. They are also alleged to have suffered severe psychological and emotional distress due to the development of gynecomastia, even after they had the tissue removed. The complaints also accuse Johnson & Johnson of concealing the risk of male breast growth from patients and the medical community, and of marketing Risperdal for use in children long before receiving clearance from the U.S. Food & Drug Administration to do so.
This past November, Johnson & Johnson reached a settlement with the U.S. Department of Justice in which it agreed to pay $2.2 billion to resolve criminal and civil charges involving the off-label marketing of Risperdal and other drugs. Among other thing, federal prosecutors had charged that Risperdal was improperly marketed for use in children. They also alleged that the company concealed the risk of male breast growth. According to the DOJ, the accord ranked among the largest health care fraud settlements in U.S. history.
[justice.gov/opa/pr/2013/November/13-ag-1170.html?source=email_rt_mc_body&app=n, DOJ, November 4, 2013]
Victims of gynecomastia allegedly associated with the use of Risperdal may be eligible to file their own Risperdal lawsuit. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit the Firm’s new Facebook page, or yourlegalhelp.com.
About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Risperdal lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.
Wright & Schulte LLC